Published in Mol Cell Biol on August 11, 2014
Desmosome regulation and signaling in disease. Cell Tissue Res (2015) 0.84
Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers. Cell Discov (2016) 0.78
Plakophilin-2 promotes activation of epidermal growth factor receptor. Mol Cell Biol (2014) 0.76
STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling. Nat Struct Mol Biol (2017) 0.76
Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes. J Cell Biol (2016) 0.75
Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFR. Receptors Clin Investig (2015) 0.75
Functional roles of MMP14 and MMP15 in early postnatal mammary gland development. Development (2016) 0.75
ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer (2005) 16.73
Oncogenic kinase signalling. Nature (2001) 16.30
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature (1992) 5.47
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol (2006) 5.10
ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol (2009) 4.40
Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One (2010) 3.96
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature (2010) 3.52
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol (1994) 3.42
GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol (2007) 2.88
The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer (2012) 2.79
Retracted Cytohesins are cytoplasmic ErbB receptor activators. Cell (2010) 2.74
Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res (2008) 1.99
Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol (2004) 1.92
Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets (2012) 1.85
Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling. J Biol Chem (2002) 1.84
Desmosomes: a role in cancer? Br J Cancer (2007) 1.55
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int J Cancer (2001) 1.46
Epidermal growth factor receptor signaling. Curr Biol (2001) 1.43
Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol (2011) 1.40
Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer (2011) 1.33
A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor. Nat Cell Biol (2010) 1.25
Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation. PLoS One (2012) 1.18
ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc Natl Acad Sci U S A (1998) 1.17
Desmosomes at a glance. J Cell Sci (2009) 1.14
Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol (2009) 1.13
Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. Cancer Res (2006) 1.09
An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells. J Proteome Res (2009) 1.07
Desmosomal plakophilin 2 as a differentiation marker in normal and malignant tissues. Differentiation (1999) 1.06
Signaling cross-talk in the resistance to HER family receptor targeted therapy. Oncogene (2013) 1.03
Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Hum Pathol (2003) 1.01
Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism. J Clin Invest (2006) 0.99
Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer. Mol Cancer (2010) 0.99
Differential expression of desmosomal plakophilins in various types of carcinomas: correlation with cell type and differentiation. Hum Pathol (2006) 0.94
Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. PLoS One (2012) 0.87
Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer. Urology (2011) 0.80
ERBB receptors in cancer: signaling from the inside. Breast Cancer Res (2011) 0.77